# FDA Inspection 1105837 - Biomat USA - September 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa/9edc483a-48df-4657-aacc-e799c6cf4522
Source feed: FDA_Inspections

> FDA Inspection 1105837 for Biomat USA on September 12, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1105837
- Company Name: Biomat USA
- Inspection Date: 2019-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1254807 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/biomat-usa/bd9ee429-feb1-4d18-ae83-f5ea07089239)
- [FDA Inspection 1254807 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/biomat-usa/d570ce51-74a8-471f-840f-297c7613ac4c)

Company: https://www.keypedia.com/companies/biomat-usa/1934ed88-29c8-4dd6-91a1-3d6f30f0e275

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d